In vitro fertilization (IVF) is emotionally and financially taxing, especially for women of advanced maternal age. As maternal age increases, the risk of chromosomal abnormalities (aneuploidy) in embryos rises, heightening fears of conditions like Trisomy 21, or Down syndrome. Capitalizing on this anxiety, the IVF industry heavily promotes Preimplantation Genetic Testing for Aneuploidy (PGT-A) as […] The post How the IVF Industry Exploits Down Syndrome Anxiety to Hard Sell the Controversial PGT-